SGLT2 Inhibitors

Type 2 Diabetes, or high levels of blood glucose, is generally a manageable disease. With proper diet, exercise, and medical professional recommended treatment, most people can live a completely normal life. If left untreated, however, Diabetes can lead to severe problems including blindness, kidney damage, and heart disease. SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors are a class of prescription medication intended to lower blood sugar in adults with Type 2 Diabetes by causing the kidneys to eliminate blood glucose through urination.

As of December 4, 2015, the FDA has updated its warnings regarding the class of Type 2 Diabetes medicines called Sodium-Glucose Cotransporter-2 Inhibitors. According to the FDA, “patients should stop taking their SGLT2 Inhibitor and seek medical attention immediately” if you become aware of any signs of ketoacidosis. This is a serious condition wherein the body produces high levels of acid in the blood (called ketones), which can lead to a diabetic coma and even death. According to the FDA, warning signs of possible ketoacidosis include nausea, vomiting, abdominal pain, fatigue, and constricted oxygen flow. The FDA also recommends being alert for signs of urinary tract infection.

If you currently take, or have taken any of the following medicines (Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance, or Glyxambi), please call the Law Offices of George Salinas today. All of these medications include at least one of the active ingredients canagliflozin, dapagliflozin, or empagliflozen, which could be harmful to your health. The Law Offices of George Salinas are here to offer you free consultation and a thorough analysis of your legal rights. We want to make sure that you receive the care, compensation, and justice you deserve. Call us today at (210) 225.0909; we’re here to help.